目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Intravenous Iron Drugs Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
3.3.4. Patent Expiry Analysis
3.3.5. Pricing Analysis

Chapter 4. Intravenous Iron Drugs Market: Product Business Analysis
4.1. Product Market Share, 2024 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Iron Dextran
4.4.1. Iron Dextran Market, 2018 - 2030 (USD Million)
4.5. Iron Sucrose
4.5.1. Iron Sucrose Market, 2018 - 2030 (USD Million)
4.6. Ferric Carboxymaltose
4.6.1. Ferric Carboxymaltose Market, 2018 - 2030 (USD Million)
4.7. Others
4.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Intravenous Iron Drugs Market: Application Business Analysis
5.1. Application Market Share, 2024 & 2030
5.2. Application Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Chronic Kidney Disease
5.4.1. Chronic Kidney Diseases Market, 2018 - 2030 (USD Million)
5.5. Inflammatory Bowel Disease
5.5.1. Inflammatory Bowel Disease Market, 2018 - 2030 (USD Million)
5.6. Cancer
5.6.1. Cancer Market, 2018 - 2030 (USD Million)
5.7. Other Diseases
5.7.1. Other Diseases Market, 2018 - 2030 (USD Million)

Chapter 6. Intravenous Iron Drugs Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030
6.4. North America
6.4.1. North America Intravenous Iron Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Target Disease Prevalence
6.4.2.3. Regulatory Framework
6.4.2.4. Reimbursement Framework
6.4.2.5. U.S. Intravenous Iron Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Target Disease Prevalence
6.4.3.3. Regulatory Framework
6.4.3.4. Reimbursement Framework
6.4.3.5. U.S. Intravenous Iron Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Target Disease Prevalence
6.4.4.3. Regulatory Framework
6.4.4.4. Reimbursement Framework
6.4.4.5. Mexico Intravenous Iron Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. Europe Intravenous Iron Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Target Disease Prevalence
6.5.2.3. Regulatory Framework
6.5.2.4. Reimbursement Framework
6.5.2.5. UK Intravenous Iron Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamics
6.5.3.2. Target Disease Prevalence
6.5.3.3. Regulatory Framework
6.5.3.4. Reimbursement Framework
6.5.3.5. Germany Intravenous Iron Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamics
6.5.4.2. Target Disease Prevalence
6.5.4.3. Regulatory Framework
6.5.4.4. Reimbursement Framework
6.5.4.5. France Intravenous Iron Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamics
6.5.5.2. Target Disease Prevalence
6.5.5.3. Regulatory Framework
6.5.5.4. Reimbursement Framework
6.5.5.5. Italy Intravenous Iron Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key Country Dynamics
6.5.6.2. Target Disease Prevalence
6.5.6.3. Regulatory Framework
6.5.6.4. Reimbursement Framework
6.5.6.5. Spain Intravenous Iron Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.7. Denmark
6.5.7.1. Key Country Dynamics
6.5.7.2. Target Disease Prevalence
6.5.7.3. Regulatory Framework
6.5.7.4. Reimbursement Framework
6.5.7.5. Denmark Intravenous Iron Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.8. Sweden
6.5.8.1. Key Country Dynamics
6.5.8.2. Target Disease Prevalence
6.5.8.3. Regulatory Framework
6.5.8.4. Reimbursement Framework
6.5.8.5. Sweden Intravenous Iron Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.9. Norway
6.5.9.1. Key Country Dynamics
6.5.9.2. Target Disease Prevalence
6.5.9.3. Regulatory Framework
6.5.9.4. Reimbursement Framework
6.5.9.5. Norway Intravenous Iron Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Intravenous Iron Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Target Disease Prevalence
6.6.2.3. Regulatory Framework
6.6.2.4. Reimbursement Framework
6.6.2.5. Japan Intravenous Iron Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Target Disease Prevalence
6.6.3.3. Regulatory Framework
6.6.3.4. Reimbursement Framework
6.6.3.5. China Intravenous Iron Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Target Disease Prevalence
6.6.4.3. Regulatory Framework
6.6.4.4. Reimbursement Framework
6.6.4.5. India Intravenous Iron Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. Australia
6.6.5.1. Key Country Dynamics
6.6.5.2. Target Disease Prevalence
6.6.5.3. Regulatory Framework
6.6.5.4. Reimbursement Framework
6.6.5.5. Australia Intravenous Iron Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.6. South Korea
6.6.6.1. Key Country Dynamics
6.6.6.2. Target Disease Prevalence
6.6.6.3. Regulatory Framework
6.6.6.4. Reimbursement Framework
6.6.6.5. South Korea Intravenous Iron Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Target Disease Prevalence
6.6.7.3. Regulatory Framework
6.6.7.4. Reimbursement Framework
6.6.7.5. Thailand Intravenous Iron Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America Intravenous Iron Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Target Disease Prevalence
6.7.2.3. Regulatory Framework
6.7.2.4. Reimbursement Framework
6.7.2.5. Japan Intravenous Iron Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Target Disease Prevalence
6.7.3.3. Regulatory Framework
6.7.3.4. Reimbursement Framework
6.7.3.5. China Intravenous Iron Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Middle East and Africa
6.8.1. Middle East and Africa Intravenous Iron Drugs Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Target Disease Prevalence
6.8.2.3. Regulatory Framework
6.8.2.4. Reimbursement Framework
6.8.2.5. South Africa Intravenous Iron Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Target Disease Prevalence
6.8.3.3. Regulatory Framework
6.8.3.4. Reimbursement Framework
6.8.3.5. Saudi Arabia Intravenous Iron Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Target Disease Prevalence
6.8.4.3. Regulatory Framework
6.8.4.4. Reimbursement Framework
6.8.4.5. UAE Intravenous Iron Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Target Disease Prevalence
6.8.5.3. Regulatory Framework
6.8.5.4. Reimbursement Framework
6.8.5.5. Kuwait Intravenous Iron Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. AbbVie Inc.
7.5.1.1. Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. AMAG Pharmaceuticals (Covis Pharma)
7.5.2.1. Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. Daiichi Sankyo Company, Ltd.
7.5.3.1. Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. Sanofi
7.5.4.1. Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. Vifor Pharma Management Ltd. (CSL)
7.5.5.1. Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. PHARMACOSMOS A/S
7.5.6.1. Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. Zydus Group
7.5.7.1. Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. Rockwell Medical, Inc.
7.5.8.1. Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global intravenous iron drugs market, by region, 2018 - 2030 (USD Million)
Table 4 Global intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 5 Global intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 6 North America intravenous iron drugs market, by country, 2018 - 2030 (USD Million)
Table 7 North America intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 8 North America intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 9 U.S. intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 10 U.S. intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 11 Canada intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 12 Canada intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 13 Mexico intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 14 Mexico intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 15 Europe intravenous iron drugs market, by country, 2018 - 2030 (USD Million)
Table 16 Europe intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 17 Europe intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 18 UK intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 19 UK intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 20 Germany intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 21 Germany intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 22 France intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 23 France intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 24 Italy intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 25 Italy intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 26 Spain intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 27 Spain intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 28 Norway intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 29 Norway intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 30 Denmark intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 31 Denmark intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 32 Sweden intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 33 Sweden intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 34 Asia Pacific intravenous iron drugs market, by country, 2018 - 2030 (USD Million)
Table 35 Asia Pacific intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 36 Asia Pacific intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 37 Japan intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 38 Japan intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 39 China intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 40 China intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 41 India intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 42 India intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 43 Australia intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 44 Australia intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 45 South Korea intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 46 South Korea intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 47 Thailand intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 48 Thailand intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 49 Latin America intravenous iron drugs market, by country, 2018 - 2030 (USD Million)
Table 50 Latin America intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 51 Latin America intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 52 Brazil intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 53 Brazil intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 54 Argentina intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 55 Argentina intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 56 Middle East & Africa Intravenous iron drugs market, by country, 2018 - 2030 (USD Million)
Table 57 Middle East & Africa intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 58 Middle East & Africa intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 59 South Africa intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 60 South Africa intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 61 Saudi Arabia intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 62 Saudi Arabia intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 63 UAE intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 64 UAE intravenous iron drugs market, by application, 2018 - 2030 (USD Million)
Table 65 Kuwait intravenous iron drugs market, by product, 2018 - 2030 (USD Million)
Table 66 Kuwait intravenous iron drugs market, by application, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Intravenous iron drugs market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Therapeutic approach and application outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Intravenous iron drugs market dynamics
Fig. 12 Intravenous iron drugs market: Porter’s five forces analysis
Fig. 13 Intravenous iron drugs market: PESTLE analysis
Fig. 14 Product market, 2018 - 2030 (USD Million)
Fig. 15 Iron Dextran market, 2018 - 2030 (USD Million)
Fig. 16 Iron Sucrose market, 2018 - 2030 (USD Million)
Fig. 17 Ferric Carboxymaltose market, 2018 - 2030 (USD Million)
Fig. 18 Others market, 2018 - 2030 (USD Million)
Fig. 19 Application market, 2018 - 2030 (USD Million)
Fig. 20 Chronic kidney disease market, 2018 - 2030 (USD Million)
Fig. 21 Inflammatory bowel disease market, 2018 - 2030 (USD Million)
Fig. 22 Cancer market, 2018 - 2030 (USD Million)
Fig. 23 Other Diseases market, 2018 - 2030 (USD Million)
Fig. 24 Intravenous iron drugs market revenue, by region
Fig. 25 Regional marketplace: Key takeaways
Fig. 26 North America intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 27 U.S. country dynamics
Fig. 28 U.S. intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 29 Canada country dynamics
Fig. 30 Canada intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 31 Mexico country dynamics
Fig. 32 Mexico intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 33 Europe intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 34 UK country dynamics
Fig. 35 UK intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 36 Germany country dynamics
Fig. 37 Germany intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 38 France country dynamics
Fig. 39 France intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 40 Italy country dynamics
Fig. 41 Italy intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 42 Spain country dynamics
Fig. 43 Spain intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 44 Norway country dynamics
Fig. 45 Norway intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 46 Sweden country dynamics
Fig. 47 Sweden intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 48 Denmark country dynamics
Fig. 49 Denmark intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 50 Asia Pacific intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 51 Japan country dynamics
Fig. 52 Japan intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 53 China country dynamics
Fig. 54 China intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 55 India country dynamics
Fig. 56 India intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 57 Australia country dynamics
Fig. 58 Australia intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 59 South Korea country dynamics
Fig. 60 South Korea intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 61 Thailand country dynamics
Fig. 62 Thailand intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 63 Latin America intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 64 Brazil country dynamics
Fig. 65 Brazil intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 66 Argentina country dynamics
Fig. 67 Argentina intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 68 MEA intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 69 South Africa country dynamics
Fig. 70 South Africa intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 71 Saudi Arabia country dynamics
Fig. 72 Saudi Arabia intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 73 UAE country dynamics
Fig. 74 UAE intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 75 Kuwait country dynamics
Fig. 76 Kuwait intravenous iron drugs market, 2018 - 2030 (USD Million)
Fig. 77 Company categorization
Fig. 78 Company market position analysis
Fig. 79 Strategic framework